NovaMedica to localize in Russia one of the most popular anti-migraine drugs in the world
21-March-2023
Merry Christmas and Happy New Year!
27-December-2022
NovaMedica registers two own-development CNS products, one without equivalents in Russia and the other – in the world
15-December-2022
A resource for anti-tumor drugs testing has been launched in Russia
23-March-2023
Building a Community of Trust in Epilepsy & Rare Syndromes
MHRA approves prostate cancer combination therapy
22-March-2023
